Biological factors of prognostic significance in locally advanced breast cancer
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 29 (3) , 259-264
- https://doi.org/10.1007/bf00666479
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyBreast Cancer Research and Treatment, 1992
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breastEuropean Journal of Cancer and Clinical Oncology, 1988
- Survival patterns in hormone treated advanced breast cancerBritish Journal of Surgery, 1986
- Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.1986
- THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*Anz Journal of Surgery, 1984
- Monoclonal antibodies to human estrogen receptor.Proceedings of the National Academy of Sciences, 1980
- Prognosis in inoperable Stage III carcinoma of the breastEuropean Journal of Cancer (1965), 1977
- ASSESSMENT OF RESPONSE TO TREATMENT IN ADVANCED BREAST CANCERThe Lancet, 1974